Despite a challenging 2024 for Boston’s life sciences market—marked by softening fundamentals and an oversupply of lab ...

As the U.S. life sciences real estate sector recovers from a challenging year in 2024, other markets across the globe, particularly in China and Europe, are gaining steam.

Successful collaborations are built on open communication and a shared commitment to both risks and rewards. These ...

Apr. 8, 2025 — A new study maps how specific lactic acid bacteria can enhance both the flavor and nutritional quality of plant-based dairy alternatives. The findings may have wide-reaching ...

Known as the home of big-name companies including Johnson & Johnson, New Jersey has become a destination for more and more ...

Featuring 50 influential people shaping the future of biotech, medicine, health care, policy, and health tech. Explore the list.

Here are the members of HiveBio's first cohort for its life sciences accelerator program geared towards underrepresented ...

Chubb has launched a new insurance product designed to provide casualty and cyber protection for life sciences companies ...

The randomized, double-blind, placebo-controlled trial aims to assess the safety, tolerability, and efficacy of intranasal foralumab in patients with na-SPMS, a form of multiple sclerosis (MS) ...

Barclays analyst Luke Sergott lowered the firm’s price target on Exact Sciences (EXAS) to $55 from $65 and keeps an Overweight rating on the ...